High-dose-rate brachytherapy boost for locally advanced cervical cancer: Oncological outcome and toxicity analysis of 4 fractionation schemes

High-dose-rate brachytherapy boost for locally advanced cervical cancer: Oncological outcome and toxicity analysis of 4 fractionation schemes

Purpose: Brachytherapy (BT) boost after radio-chemotherapy (RCT) is a standard of care in the management of locally advanced cervical cancer (LACC). As there is no consensus on high-dose-rate (HDR) BT fractionation schemes, our aim was to report the oncological outcome and toxicity profile of four d...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Maud le Guyader, Daniel Lam Cham Kee, Brice Thamphya, Renaud Schiappa, Mathieu Gautier, Marie-Eve Chand-Fouche, Jean-Michel Hannoun-Levi
Format: article
Langue:EN
Publié: Elsevier 2022
Sujets:
Cervical cancer
Brachytherapy
High-dose-rate
Fractionation scheme
Medical physics. Medical radiology. Nuclear medicine
R895-920
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Accès en ligne:https://doaj.org/article/29529ff497fa41c3bd5287d8155c5c6b
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/29529ff497fa41c3bd5287d8155c5c6b

Documents similaires